Literature DB >> 21654538

Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus.

Phil A Hart1, Pratima Kamada, Kari G Rabe, Sunil Srinivasan, Ananda Basu, Gaurav Aggarwal, Suresh T Chari.   

Abstract

OBJECTIVES: New-onset diabetes mellitus (DM) may herald pancreatic cancer (PaC). We determined whether changes in body weight distinguished PaC-associated DM (PaCDM) from type 2 DM.
METHODS: Among Olmsted County residents, we identified 29 PaCDM and 43 type 2 DM subjects who had serial fasting blood glucose measurements, new-onset DM, and no cancer-specific symptoms at DM onset. We compared body weight (kg) and fasting blood glucose (mg/dL) at DM onset, 1 to 2 years before and at index date in the 2 groups.
RESULTS: Fasting blood glucose values were similar before and at the onset of DM. Before onset of DM, PaCDM and type 2 DM subjects had similar body weight (P = 0.80). However, at onset of DM, 59% of PaCDM subjects lost weight versus 30% of type 2 DM subjects (P = 0.02). At onset of DM, 56% of type 2 DM subjects gained weight versus 31% of PaCDM subjects (P = 0.04). By index date, PaCDM subjects lost more weight than type 2 DM subjects did (8.3 ± 8.3 vs 0.8 ± 4.8 kg, P < 0.01).
CONCLUSIONS: Although new-onset primary type 2 DM is typically associated with weight gain, weight loss frequently precedes onset of PaCDM. The paradoxical development of diabetes in the face of ongoing weight loss may be an important clue to understanding the pathogenesis of PaCDM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654538      PMCID: PMC3118443          DOI: 10.1097/MPA.0b013e318220816a

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  18 in total

1.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

2.  Purification and characterization of a tumor lipid-mobilizing factor.

Authors:  P T Todorov; T M McDevitt; D J Meyer; H Ueyama; I Ohkubo; M J Tisdale
Journal:  Cancer Res       Date:  1998-06-01       Impact factor: 12.701

3.  Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?

Authors:  Tomohito Gohda; Yuichiro Makita; Toshihide Shike; Mitsuo Tanimoto; Kazuhiko Funabiki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

4.  Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis.

Authors:  Mario Pelaez-Luna; Naoki Takahashi; Joel G Fletcher; Suresh T Chari
Journal:  Am J Gastroenterol       Date:  2007-10       Impact factor: 10.864

5.  Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters.

Authors:  I Díez-Itza; L M Sánchez; M T Allende; F Vizoso; A Ruibal; C López-Otín
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

7.  Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?

Authors:  J Damiano; L Bordier; J P Le Berre; J Margery; O Dupuy; H Mayaudon; B Bauduceau
Journal:  Diabetes Metab       Date:  2004-04       Impact factor: 6.041

8.  Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis.

Authors:  Sumana Gangi; J G Fletcher; Mark A Nathan; Jared A Christensen; William S Harmsen; Brian S Crownhart; Suresh T Chari
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

9.  Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.

Authors:  John DeWitt; Benedict Devereaux; Melissa Chriswell; Kathleen McGreevy; Thomas Howard; Thomas F Imperiale; Donato Ciaccia; Kathleen A Lane; Dean Maglinte; Kenyon Kopecky; Julia LeBlanc; Lee McHenry; James Madura; Alex Aisen; Harvey Cramer; Oscar Cummings; Stuart Sherman
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

10.  Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.

Authors:  S T Russell; M J Tisdale
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

View more
  32 in total

1.  Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest.

Authors:  Sunil G Sheth; Darwin L Conwell; David C Whitcomb; Matthew Alsante; Michelle A Anderson; Jamie Barkin; Randall Brand; Gregory A Cote; Steven D Freedman; Andres Gelrud; Fred Gorelick; Linda S Lee; Katherine Morgan; Stephen Pandol; Vikesh K Singh; Dhiraj Yadav; C Mel Wilcox; Phil A Hart
Journal:  Pancreatology       Date:  2017-02-28       Impact factor: 3.996

Review 2.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

Review 3.  Diagnosis and staging of pancreatic ductal adenocarcinoma.

Authors:  C Guillén-Ponce; J Blázquez; I González; E de-Madaria; J Montáns; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

Review 4.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

5.  A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.

Authors:  Ben Boursi; Brian Finkelman; Bruce J Giantonio; Kevin Haynes; Anil K Rustgi; Andrew D Rhim; Ronac Mamtani; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2016-12-05       Impact factor: 22.682

6.  Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.

Authors:  Raghuwansh P Sah; Ayush Sharma; Sajan Nagpal; Sri Harsha Patlolla; Anil Sharma; Harika Kandlakunta; Vincent Anani; Ramcharan Singh Angom; Amrit K Kamboj; Nazir Ahmed; Sonmoon Mohapatra; Sneha Vivekanandhan; Kenneth A Philbrick; Alexander Weston; Naoki Takahashi; James Kirkland; Naureen Javeed; Aleksey Matveyenko; Michael J Levy; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Gastroenterology       Date:  2019-01-22       Impact factor: 22.682

7.  Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.

Authors:  Suguru Mizuno; Yousuke Nakai; Hiroyuki Isayama; Ayako Yanai; Naminatsu Takahara; Koji Miyabayashi; Keisuke Yamamoto; Kazumichi Kawakubo; Dai Mohri; Hirofumi Kogure; Takashi Sasaki; Natsuyo Yamamoto; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Hideaki Ijichi; Keisuke Tateishi; Masao Akanuma; Minoru Tada; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-06-28       Impact factor: 7.527

8.  Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.

Authors:  Kimberly A Kelly; Michael A Hollingsworth; Randall E Brand; Christina H Liu; Vikesh K Singh; Sudhir Srivastava; Ajay D Wasan; Dhiraj Yadav; Dana K Andersen
Journal:  Pancreas       Date:  2015-11       Impact factor: 3.327

9.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

Review 10.  Diabetes and pancreatic cancer.

Authors:  T Muniraj; S T Chari
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.